CN102037141B - 用于表征蠕虫卵特别是鞭虫卵的生物学活性的方法 - Google Patents

用于表征蠕虫卵特别是鞭虫卵的生物学活性的方法 Download PDF

Info

Publication number
CN102037141B
CN102037141B CN200980118522.9A CN200980118522A CN102037141B CN 102037141 B CN102037141 B CN 102037141B CN 200980118522 A CN200980118522 A CN 200980118522A CN 102037141 B CN102037141 B CN 102037141B
Authority
CN
China
Prior art keywords
eggs
whipworm
determining
larvae
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200980118522.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN102037141A (zh
Inventor
伯恩哈德·特维斯
鲁道夫·威廉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Falk Pharma GmbH
Original Assignee
Dr Falk Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Falk Pharma GmbH filed Critical Dr Falk Pharma GmbH
Publication of CN102037141A publication Critical patent/CN102037141A/zh
Application granted granted Critical
Publication of CN102037141B publication Critical patent/CN102037141B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN200980118522.9A 2008-05-21 2009-05-20 用于表征蠕虫卵特别是鞭虫卵的生物学活性的方法 Expired - Fee Related CN102037141B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08009344.6 2008-05-21
EP08009344A EP2123774A1 (de) 2008-05-21 2008-05-21 Verfahren zur Charakterisierung der biologischen Aktivität von Helminth-Eiern
PCT/EP2009/056106 WO2009156232A1 (de) 2008-05-21 2009-05-20 Verfahren zur charakterisierung der biologischen aktivität von helminth-eiern, nämlich von trichuris eiern

Publications (2)

Publication Number Publication Date
CN102037141A CN102037141A (zh) 2011-04-27
CN102037141B true CN102037141B (zh) 2014-02-26

Family

ID=39768691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980118522.9A Expired - Fee Related CN102037141B (zh) 2008-05-21 2009-05-20 用于表征蠕虫卵特别是鞭虫卵的生物学活性的方法

Country Status (17)

Country Link
US (1) US8993332B2 (https=)
EP (2) EP2123774A1 (https=)
JP (1) JP5753778B2 (https=)
CN (1) CN102037141B (https=)
AU (1) AU2009262381B2 (https=)
CA (1) CA2723402C (https=)
CY (1) CY1116916T1 (https=)
DK (1) DK2279264T3 (https=)
ES (1) ES2552356T3 (https=)
HR (1) HRP20151173T1 (https=)
HU (1) HUE026151T2 (https=)
PL (1) PL2279264T3 (https=)
PT (1) PT2279264E (https=)
RU (1) RU2540145C2 (https=)
SI (1) SI2279264T1 (https=)
UA (1) UA103769C2 (https=)
WO (1) WO2009156232A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2492637C2 (ru) * 2011-07-26 2013-09-20 Закрытое акционерное общество "АЛЬФА-ТЭК" Способ предынкубационной обработки яиц препаратом галосепт
US9224200B2 (en) 2012-04-27 2015-12-29 Parasite Technologies A/S Computer vision based method for extracting features relating to the developmental stages of Trichuris spp. eggs
RU2609145C2 (ru) * 2015-06-08 2017-01-30 ФАНО России Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений им. К.И. Скрябина (ФГБНУ "ВНИИП им. К.И. Скрябина") Способ сбора максимального количества зрелых (=оплодотворённых) яиц (in vitro) от самок возбудителя паразитарного зооноза trichuris (=trichocephalus) suis
US9603875B1 (en) 2016-01-07 2017-03-28 NeuOva, LLC Method of making a consumable product with purified embryonated Trichuris suis ova
JP6231709B1 (ja) 2016-05-31 2017-11-15 シスメックス株式会社 蛍光画像分析装置および分析方法
CN106689063B (zh) * 2016-12-07 2020-03-17 中国科学院动物研究所 一种稻螟赤眼蜂的人工繁育生产方法
WO2025259635A1 (en) * 2024-06-10 2025-12-18 Parasight System Inc. Methods for analyzing fecal matter using fluorochromes that covalently bond to parasitic material

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066671A3 (en) * 2001-02-16 2003-11-13 Promega Corp Improved method for detection of atp
WO2007076868A2 (en) * 2005-12-30 2007-07-12 Parasite Technologies A/S Composition comprising parasite eggs and methods for isolation and storage of parasite eggs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2315790C (en) 1997-12-31 2015-10-06 University Of Iowa Research Foundation Use of parasitic biological agents for prevention and control of autoimmune diseases
DE102006023906A1 (de) 2006-05-19 2007-11-22 Ovamed Gmbh Verfahren zum Nachweis der Viabilität

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066671A3 (en) * 2001-02-16 2003-11-13 Promega Corp Improved method for detection of atp
WO2007076868A2 (en) * 2005-12-30 2007-07-12 Parasite Technologies A/S Composition comprising parasite eggs and methods for isolation and storage of parasite eggs

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A real-time PCR method for quantifying viable ascaris eggs using the first internally transcribed spacer region of ribosomal DNA;Brian M. Pecson 等;《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》;20061231;第72卷;第7864-7872页 *
Detection of a single viable Cryptosporidium parvum oocyst in environmental water concentrates by reverse transcription-PCR;TIMOTHY STINEAR 等;《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》;19960930;第62卷(第9期);第3385-3390页 *
Trichuris suis population dynamics following a primary experimental infection;Helene Kringel 等1;《Veterinary Parasitology》;20061231;第139卷;第132-139页 *

Also Published As

Publication number Publication date
CY1116916T1 (el) 2017-04-05
JP5753778B2 (ja) 2015-07-22
WO2009156232A1 (de) 2009-12-30
JP2011523847A (ja) 2011-08-25
RU2010152016A (ru) 2012-06-27
PL2279264T3 (pl) 2016-01-29
SI2279264T1 (sl) 2015-11-30
RU2540145C2 (ru) 2015-02-10
CN102037141A (zh) 2011-04-27
EP2279264B1 (de) 2015-08-19
US8993332B2 (en) 2015-03-31
UA103769C2 (ru) 2013-11-25
HRP20151173T1 (hr) 2015-12-04
EP2279264A1 (de) 2011-02-02
ES2552356T3 (es) 2015-11-27
DK2279264T3 (en) 2015-11-23
AU2009262381A1 (en) 2009-12-30
AU2009262381B2 (en) 2015-03-26
US20110191869A1 (en) 2011-08-04
EP2123774A1 (de) 2009-11-25
HK1147113A1 (en) 2011-07-29
US20120060229A9 (en) 2012-03-08
PT2279264E (pt) 2015-11-20
WO2009156232A9 (de) 2010-02-18
CA2723402C (en) 2018-06-19
CA2723402A1 (en) 2009-12-30
HUE026151T2 (en) 2016-05-30

Similar Documents

Publication Publication Date Title
CN102037141B (zh) 用于表征蠕虫卵特别是鞭虫卵的生物学活性的方法
Troha et al. Methods for the study of innate immunity in Drosophila melanogaster
Pu et al. ATP-dependent dynamic protein aggregation regulates bacterial dormancy depth critical for antibiotic tolerance
Sanderson et al. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis
TW201713775A (zh) 用於自複雜的異源群集中分析微生物品系、預測及識別其機能性關係及交互作用，且依據前述選擇並合成微生物系集之方法、裝置及系統
CN110023761B (zh) 制备活的微生物样品和微生物用于随后的质谱测量和评估
Clanner‐Engelshofen et al. Corynebacterium kroppenstedtii subsp. demodicis is the endobacterium of Demodex folliculorum
Lange et al. A Galleria mellonella
WO2012117431A1 (en) Method and reagent kit for the identification of biological fluids in a sample
Yang et al. A role for cell polarity in lifespan and mitochondrial quality control in the budding yeast Saccharomyces cerevisiae
EP3134538B1 (en) Rapid determination of bacterial susceptibility to an antibiotic at the point of care
Sojka et al. Qualitative investigation of µ-and κ-opioid receptor distribution in the brains of budgerigars (Melopsittacus undulatus)
Kato et al. Introduction of foreign DNA into the water flea, Daphnia magna, by electroporation
RU2850788C1 (ru) Способ идентификации Vibrio vulnificus методом ПЦР с гибридизационно-флуоресцентной детекцией в режиме реального времени
US20240352525A1 (en) Microrna assay for detection of johne's infection and disease
Elya et al. A fungal pathogen that robustly manipulates the behavior of Drosophila melanogaster in the laboratory
RU2760788C1 (ru) ПРЕЦИЗИОННЫЙ СПОСОБ СРАВНИТЕЛЬНОЙ ЭКСПРЕСС-ОЦЕНКИ ЭФФЕКТИВНОСТИ АНТИМИКРОБНЫХ ВЕЩЕСТВ В ОТНОШЕНИИ УСЛОВНО ПАТОГЕННОГО ВИДА Pseudomonas aeruginosa
RU2822161C1 (ru) Способ выявления РНК вируса Хендра вида Hendra henipavirus методом ОТ-ПЦР в реальном времени
HK1147113B (en) Method for characterising the biological activity of trichuris eggs
Pandey et al. Identification and culture test
Manam et al. ISOLATION AND IDENTIFICATION OF BIOLUMINESCENT PHOTOBACTERIUM LEIOGNATHI FROM MARINE SQUID BY GENOMIC DNA AND RESTRICTION SITE ANALYSIS
Okahata et al. Anticancer drugs affect temperature signaling and epigenetic factors in the cold tolerance of Caenorhabditis elegans
Zhai et al. CRISPR-Cas12a Test Strip (CRISPR/CAST) Package: Poverty Family Pasture Health Patron Saint for Livestocks Free from Brucella Infection
RU2566558C1 (ru) СПОСОБ ОПРЕДЕЛЕНИЯ ПОЛИАМИНА КАДАВЕРИНА ПРИ МОДЕЛИРОВАНИИ СТРЕССОВЫХ СИТУАЦИЙ Vibrio cholerae 01 И 0139 СЕРОГРУПП
RU2483114C1 (ru) СПОСОБ ВЫЯВЛЕНИЯ ГЕНОВ, ДЕТЕРМИНИРУЮЩИХ АДГЕЗИНЫ, ГЕМОЛИЗИНЫ, МАННОЗА-РЕЗИСТЕНТНЫЕ ГЕМАГГЛЮТИНИНЫ У ГЕНИТАЛЬНЫХ ШТАММОВ Escherichia coli

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140226

Termination date: 20180520

CF01 Termination of patent right due to non-payment of annual fee